FR11C0017I2 - Use of spinosad or a formulation comprising spinosad - Google Patents

Use of spinosad or a formulation comprising spinosad

Info

Publication number
FR11C0017I2
FR11C0017I2 FR11C0017C FR11C0017C FR11C0017I2 FR 11C0017 I2 FR11C0017 I2 FR 11C0017I2 FR 11C0017 C FR11C0017 C FR 11C0017C FR 11C0017 C FR11C0017 C FR 11C0017C FR 11C0017 I2 FR11C0017 I2 FR 11C0017I2
Authority
FR
France
Prior art keywords
spinosad
formulations
controlling
formulation
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR11C0017C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22526570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR11C0017(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR11C0017I1 publication Critical patent/FR11C0017I1/fr
Application granted granted Critical
Publication of FR11C0017I2 publication Critical patent/FR11C0017I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The invention provides single-dose oral formulations for controlling an ectoparasite infestation on a companion animal for a prolonged time, said formulations comprising a spinosyn component, or a physiologically acceptable derivative or salt thereof, and a carrier in oral dosage form. It also provides methods for controlling such infestations comprising orally administering a single dose of these formulations to the animal.
FR11C0017C 1999-08-12 2011-05-24 Use of spinosad or a formulation comprising spinosad Active FR11C0017I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14861899P 1999-08-12 1999-08-12
PCT/US2000/019557 WO2001011963A1 (en) 1999-08-12 2000-08-02 Oral treatment of companion animals with ectoparasiticidal spinosyns

Publications (2)

Publication Number Publication Date
FR11C0017I1 FR11C0017I1 (en) 2011-08-07
FR11C0017I2 true FR11C0017I2 (en) 2012-06-15

Family

ID=22526570

Family Applications (1)

Application Number Title Priority Date Filing Date
FR11C0017C Active FR11C0017I2 (en) 1999-08-12 2011-05-24 Use of spinosad or a formulation comprising spinosad

Country Status (25)

Country Link
US (1) US6664237B1 (en)
EP (1) EP1207756B1 (en)
JP (2) JP5046455B2 (en)
KR (1) KR100706146B1 (en)
AT (1) ATE324039T1 (en)
AU (1) AU775488B2 (en)
BE (1) BE2011C013I2 (en)
BR (1) BR0013116B1 (en)
CA (1) CA2379329C (en)
CO (1) CO5410187A1 (en)
CY (1) CY1105000T1 (en)
DE (2) DE122011100022I1 (en)
DK (1) DK1207756T3 (en)
ES (1) ES2261229T3 (en)
FR (1) FR11C0017I2 (en)
HU (1) HUP0202825A2 (en)
IL (2) IL147828A0 (en)
MX (1) MXPA02001505A (en)
MY (1) MY125485A (en)
NO (1) NO20020686L (en)
NZ (1) NZ516790A (en)
PT (1) PT1207756E (en)
TW (1) TWI244373B (en)
WO (1) WO2001011963A1 (en)
ZA (1) ZA200200565B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933318B1 (en) 1999-08-12 2005-08-23 Eli Lilly And Company Topical organic ectoparasiticidal formulations
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
DE10135550A1 (en) * 2001-07-20 2003-01-30 Bayer Cropscience Ag Process for the preparation of new spinosyn derivatives
ATE514337T1 (en) 2001-09-17 2011-07-15 Lilly Co Eli PESTICIDE FORMULATIONS
ES2315740T3 (en) * 2003-11-04 2009-04-01 Intervet International Bv ECTOPARASITICID FORMULATIONS OF SPINOSINES AND PESTICIDES OF AZOL.
DK1731512T3 (en) 2004-03-05 2015-01-05 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide AND INSTRUMENTS FOR COMBATING HARMFUL ORGANISMS
SG159395A1 (en) * 2004-04-29 2010-03-30 Lilly Co Eli Use of spinosyns for wound healing
AU2004319804B2 (en) 2004-04-29 2010-08-05 Elanco Us Inc. Use Of Spinosyns For Wound Healing
MX2007014790A (en) * 2005-05-26 2008-02-15 Lilly Co Eli Improved fish production.
KR100855417B1 (en) * 2006-10-27 2008-08-29 일라이 릴리 앤드 캄파니 A Pharmaceutical Composition for Wound Healing Comprising Spinosyns
NO2957284T3 (en) 2007-06-27 2018-06-16
US9820977B2 (en) 2008-10-03 2017-11-21 Bayer Healthcare Llc Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
UA108200C2 (en) * 2009-05-08 2015-04-10 MEDICINAL FORMS AND METHODS FOR THE USE OF ECTOPAROSITOCIDES
AU2013273709B2 (en) * 2009-05-08 2015-04-23 Eli Lilly And Company Ectoparasiticidal methods and formulations
TWI510189B (en) * 2009-06-19 2015-12-01 Lilly Co Eli Ectoparasiticidal methods and formulations
WO2010150100A1 (en) 2009-06-24 2010-12-29 Entarco Sa The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
KR20150080647A (en) * 2010-01-25 2015-07-09 일라이 릴리 앤드 캄파니 Methods for internally controlling or treating equine bot larvae
EP2635122A1 (en) * 2010-11-05 2013-09-11 Eli Lilly and Company Methods for inhibiting insect infestations
ITMI20111945A1 (en) * 2011-10-26 2013-04-27 Zapi Ind Chimiche Spa FORMULATION IN A SUITABLE FORM TO VEHICLE A DOSED QUANTITY OF AN ACTIVE SUBSTANCE
CN103125501A (en) * 2011-11-30 2013-06-05 上海农乐生物制品股份有限公司 Abamectin-spinosad emulsion in water and preparing method thereof
AR091769A1 (en) 2012-07-26 2015-02-25 Lilly Co Eli ORAL FORMULATIONS OF SINGLE DOSE AND METHODS FOR THE TREATMENT OF CATS WITH ECINOPARASITICIDE ESPINOSAD
MX2015006041A (en) 2012-11-14 2015-08-07 Lilly Co Eli Ectoparasiticidal methods and formulations.
WO2020012406A1 (en) * 2018-07-11 2020-01-16 Jubilant Generics Limited Veterinary dosage forms
CN109221133A (en) * 2018-09-28 2019-01-18 绩溪农华生物科技有限公司 A kind of Pleocidin synergistic aqueous emulsion and preparation method thereof
JP2024513690A (en) * 2021-03-11 2024-03-27 イン ザ ボウル アニマル ヘルス，インコーポレーテッド Methods for controlling flea and tick infestations in mammals - Patents.com
WO2022192618A1 (en) * 2021-03-11 2022-09-15 In The Bowl Animal Health, Inc. Feed and methods for controlling tick infestations in a mammal
WO2022271937A2 (en) * 2021-06-25 2022-12-29 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling flea infestations in a feline
WO2022271924A1 (en) * 2021-06-25 2022-12-29 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling flea infestations in a feline

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US576253A (en) * 1897-02-02 Manhole-cover
US5362634A (en) 1989-10-30 1994-11-08 Dowelanco Process for producing A83543 compounds
OA09249A (en) 1988-12-19 1992-06-30 Lilly Co Eli Compounds of macrolides.
JPH0375316A (en) * 1989-08-18 1991-03-29 Tokyo Gas Denro Kk Heat treatment furnace
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5202242A (en) 1991-11-08 1993-04-13 Dowelanco A83543 compounds and processes for production thereof
US5227295A (en) 1991-11-08 1993-07-13 Dowelanco Process for isolating A83543 and its components
US5539089A (en) 1991-11-08 1996-07-23 Dowelanco A83543 aglycones and pseudoglycones
US5591606A (en) * 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
WO1994020518A1 (en) 1993-03-12 1994-09-15 Dowelanco New a83543 compounds and process for production thereof
EP0837870B1 (en) 1995-06-14 2002-07-24 Dow AgroSciences LLC Synthetic modification to spinosyn compounds
US5695776A (en) 1996-03-12 1997-12-09 Fmc Corporation Termite bait apparatus having grooves
US6001981A (en) * 1996-06-13 1999-12-14 Dow Agrosciences Llc Synthetic modification of Spinosyn compounds
GB9624501D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Insecticial compositions and method
JPH11139912A (en) * 1997-11-06 1999-05-25 Nissan Chem Ind Ltd Stabilized agrochemical composition
NZ525906A (en) * 1997-12-23 2005-03-24 Syngenta Participations Ag Use of the macrolides abamectin, emamectin, and spinosad in pest control for protecting plant propagation material
TR200003818T2 (en) 1998-07-02 2001-06-21 Eli Lilly And Company Formulations for lice control in humans.
WO2000060940A1 (en) 1999-04-12 2000-10-19 Dow Agrosciences Llc Aqueous dispersions of agricultural chemicals
WO2001011961A1 (en) 1999-08-12 2001-02-22 Eli Lilly And Company Control of ectoparasites using spinosyns
JP2003520779A (en) 1999-08-12 2003-07-08 イーライ・リリー・アンド・カンパニー Topical organic ectoparasiticide formulation
KR100731248B1 (en) 1999-09-13 2007-06-25 다우 아그로사이언시즈 엘엘씨 Pesticidal Macrolides
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations

Also Published As

Publication number Publication date
IL147828A (en) 2006-08-20
ZA200200565B (en) 2003-11-26
CA2379329A1 (en) 2001-02-22
AU775488B2 (en) 2004-08-05
JP5046455B2 (en) 2012-10-10
HUP0202825A2 (en) 2003-03-28
MY125485A (en) 2006-08-30
EP1207756A1 (en) 2002-05-29
CY1105000T1 (en) 2010-03-03
NO20020686L (en) 2002-04-09
JP2012001563A (en) 2012-01-05
PT1207756E (en) 2006-07-31
NZ516790A (en) 2003-03-28
CA2379329C (en) 2009-10-20
BR0013116B1 (en) 2013-01-22
FR11C0017I1 (en) 2011-08-07
DE60027575T2 (en) 2007-02-15
ES2261229T3 (en) 2006-11-16
BR0013116A (en) 2002-04-30
AU6747600A (en) 2001-03-13
IL147828A0 (en) 2002-08-14
TWI244373B (en) 2005-12-01
MXPA02001505A (en) 2002-07-02
JP2003506463A (en) 2003-02-18
DK1207756T3 (en) 2006-08-14
CO5410187A1 (en) 2004-06-30
KR100706146B1 (en) 2007-04-11
DE60027575D1 (en) 2006-06-01
WO2001011963A1 (en) 2001-02-22
US6664237B1 (en) 2003-12-16
NO20020686D0 (en) 2002-02-11
EP1207756B1 (en) 2006-04-26
ATE324039T1 (en) 2006-05-15
DE122011100022I1 (en) 2011-10-20
BE2011C013I2 (en) 2019-10-16
KR20020032550A (en) 2002-05-03
JP5427217B2 (en) 2014-02-26

Similar Documents

Publication Publication Date Title
FR11C0017I2 (en) Use of spinosad or a formulation comprising spinosad
DZ3227A1 (en) PHARMACEUTICAL COMPOSITIONS PROVIDING IMPROVED DRUG CONCENTRATIONS
BR0015188A (en) Pharmaceutical compositions
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
BG66093B1 (en) Controlled release compositions comprising nimesulide
ATE224717T1 (en) ORAL MEDICINAL PREPARATIONS CONTAINING A BENZHYDRYLPIPERAZINE AND A CYCLODEXTRIN
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
CY1107819T1 (en) PHARMACEUTICAL FORM OF OLANZAPIN
DE59907481D1 (en) CONTROLLING RELEASING PHARMACEUTICAL COMPOSITION WITH TILIDINE MESYLATE AS AN ACTIVE SUBSTANCE
BR9608392A (en) Multiparticulate controlled-release preparation and tablet dosage form.
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
CA2385755A1 (en) Prevention of colorectal cancer
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
PT1202956E (en) THERAPEUTIC AND / OR NURITIONALLY IMPROVED DERIVATIVES OF ACTIVE INGREDIENTS AND ORAL ADMINISTRATION COMPOSITIONS CONTAINING THE SAME
GEP20043377B (en) Pharmaceutical Complex
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
CA2409845A1 (en) Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
DE69902925T2 (en) New injectable medicinal preparations containing RAMOPLAN
TH69069A (en) Treatment of pest infestations in pets by giving them by mouth.
SE9803277D0 (en) Novel compounds
TH32452A (en) Deodorant